Benzinga - by Lisa Levin, Benzinga Editor.
The Dow Jones closed higher on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
Remark Holdings
- The Trade: Remark Holdings, Inc. (NASDAQ: MARK) Director Theodore P Botts acquired a total of 8,000 shares an average price of $0.61. To acquire these shares, it cost around $4,851.
- What’s Happening: Remark Hldgs posted a narrower second-quarter loss.
- What Remark Holdings Does: Remark Holdings Inc delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes.
- The Trade: NeuBase Therapeutics, Inc. (NASDAQ: NBSE) 10% owner Symetryx Corp acquired a total of 61,076 shares at an average price of $0.98. The insider spent around $59,732.
- What’s Happening: Symetryx Corporation acquired a 20% stake in the company and urged the board to issue a special $1 per share dividend.
- What NeuBase Therapeutics Does: NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides.
- The Trade: Globalstar, Inc. (NYSE: GSAT) Director James Monroe III acquired a total of 5,080,416 shares at an average price of $1.52. To acquire these shares, it cost around $7.72 million.
- What’s Happening: Globalstar appointed Paul Jacobs to CEO and announced an agreement to license for XCOM Labs technology.
- What Globalstar Does: Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services.
Check This Out: Top 5 Industrials Stocks That Could Lead To Your Biggest Gains In September
Don’t forget to check out our premarket coverage here
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.